Little-known enzyme could supercharge immune cells to tackle cancer
Supercharging immune cells could provide an effective way to tackle cancer, according to new research by scientists in Scotland.
Supercharging immune cells could provide an effective way to tackle cancer, according to new research by scientists in Scotland.
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of vaccines and immune checkpoint inhibitor drugs, but it’s not always clear which therapy is inducing what type of response. To help …
Allergies and asthma affect an increasing number of children worldwide, but now an international research group led by DTU has identified a previously unknown mechanism that can reduce the risk of allergies and asthma later in life. The study shows tha…
Parkinson’s disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of dopamine-producing neurons in the substantia nigra, a brain region essential for motor control. Clinically, it is marked by tremor, rigidity, br…
Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, movement, balance and mental function. In MS, the immune system mistakenly starts attacking myelin, the protective sheath that…
Scientists have made a discovery that helps explain why humans and animals are so susceptible to contracting tuberculosis (TB)—and it involves the bacteria harnessing part of the immune system meant to protect against infection.
Researchers have developed a new class of antibodies that amplify the immune system’s ability to fight cancer. By clustering immune receptors that normally receive weak signals from tumors, these four-pronged antibodies push T cells into full attack mo…
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell atlas, which includes robust patient outcome data, p…
In 2024, 31.7% of adults and 29.5% of children had a diagnosed seasonal allergy, diagnosed eczema, or a diagnosed food allergy in the United States, according to two data briefs published online Jan. 8 by the National Center for Health Statistics.
Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system long after infection. Researchers now link symptoms to lingering virus, inflammation, micro-clots, and disrupted energy metabo…